Search results
Bancel Philanthropies is the family philanthropy of Brenda and Stéphane Bancel. We view love as our most untapped resource. We invest in people and programs with the potential to transform lives, advance justice, and heal communities.
- Our Structure
Bancel Philanthropies provides grants and support through...
- Grant Recipients
The Equal Justice Initiative (EJI) is a non-profit...
- Contact
We appreciate your interest… We currently are not accepting...
- Champions of Love
Champions of Love is a sister initiative of Bancel...
- Our Structure
Stéphane Bancel (born 20 July 1972) is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly 8% stake in the publicly...
Apr 24, 2023 · Bancel Philanthropies is the family philanthropy of Brenda and Stéphane Bancel, and invests in people and programs with the potential to transform lives, advance justice and heal communities. “Stéphane and I believe that access to education helps students reach their full potential,” said Brenda Bancel.
People also ask
Who is Stéphane Bancel?
What is Bancel Philanthropies?
Who is Stéphane Bancel & Olivier Leclerc?
What did Stéphane Bancel say to Rigoberto Hernandez?
Aug 27, 2021 · Stéphane Bancel: Some mutations of the COVID-19 virus will likely have no impact on our vaccine’s efficacy, while others might. With several mutations, there is more and more “drift” from the original SARS-CoV-2 that was sequenced.
Jul 11, 2023 · Tue, Jul 11, 2023, 5:36 PM 4 min read. CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ -- The Angiogenesis Foundation, a leading nonprofit organization at the forefront of medical innovation, is...
Jun 7, 2021 · In this episode, we talk to Stéphane Bancel, CEO of Moderna, a biotech company that developed one of the three emergency-approved COVID-19 vaccines in the United States. The Moderna vaccine is unique in that it uses a new technology that has been decades in the making called messenger RNA, or mRNA.